
Michael Pervan
Examiner (ID: 11308, Phone: (571)272-0910 , Office: P/2621 )
| Most Active Art Unit | 2621 |
| Art Unit(s) | 2693, 2677, 2691, 2629, 2621 |
| Total Applications | 1288 |
| Issued Applications | 1041 |
| Pending Applications | 53 |
| Abandoned Applications | 213 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7269843
[patent_doc_number] => 20040058361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Antibacterial treatments'
[patent_app_type] => new
[patent_app_number] => 10/451510
[patent_app_country] => US
[patent_app_date] => 2003-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7952
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058361.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451510
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451510 | Antibacterial treatments | Jun 19, 2003 | Abandoned |
Array
(
[id] => 5630998
[patent_doc_number] => 20060147466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Mucosal combination vaccines for bacterial meningitis'
[patent_app_type] => utility
[patent_app_number] => 10/514208
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6019
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10514208
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/514208 | Mucosal combination vaccines for bacterial meningitis | May 13, 2003 | Abandoned |
Array
(
[id] => 6912339
[patent_doc_number] => 20050176097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Bacillus host cell'
[patent_app_type] => utility
[patent_app_number] => 10/510812
[patent_app_country] => US
[patent_app_date] => 2003-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5280
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10510812
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/510812 | Bacillus host cell | Mar 24, 2003 | Abandoned |
Array
(
[id] => 397369
[patent_doc_number] => 07294337
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-13
[patent_title] => 'Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies'
[patent_app_type] => utility
[patent_app_number] => 10/509255
[patent_app_country] => US
[patent_app_date] => 2003-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5050
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/294/07294337.pdf
[firstpage_image] =>[orig_patent_app_number] => 10509255
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/509255 | Use of Lactobacillus farciminis for the prevention or treatment of digestive pathologies | Mar 20, 2003 | Issued |
Array
(
[id] => 6990830
[patent_doc_number] => 20050089867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Antigen fragments for the diagnosis of toxoplasma gondii'
[patent_app_type] => utility
[patent_app_number] => 10/508622
[patent_app_country] => US
[patent_app_date] => 2003-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10456
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089867.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508622
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508622 | Antigen fragments for the diagnosis of Toxoplasma gondii | Mar 17, 2003 | Issued |
Array
(
[id] => 7103920
[patent_doc_number] => 20050106646
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'In vitro serological diagnosis method of diagnosing infective endocarditis'
[patent_app_type] => utility
[patent_app_number] => 10/507646
[patent_app_country] => US
[patent_app_date] => 2003-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3924
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106646.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507646
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507646 | In vitro serological diagnosis method of diagnosing infective endocarditis | Mar 10, 2003 | Abandoned |
Array
(
[id] => 7176259
[patent_doc_number] => 20050123557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'AntiI-protozoal vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/506053
[patent_app_country] => US
[patent_app_date] => 2003-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 12580
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123557.pdf
[firstpage_image] =>[orig_patent_app_number] => 10506053
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/506053 | AntiI-protozoal vaccine | Feb 27, 2003 | Abandoned |
Array
(
[id] => 7234293
[patent_doc_number] => 20050079597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Antimicrobial composition'
[patent_app_type] => utility
[patent_app_number] => 10/505001
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6639
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079597.pdf
[firstpage_image] =>[orig_patent_app_number] => 10505001
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/505001 | Antimicrobial composition | Feb 20, 2003 | Issued |
Array
(
[id] => 7103405
[patent_doc_number] => 20050106131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Photoprotective orally administrable composition for skin'
[patent_app_type] => utility
[patent_app_number] => 10/504906
[patent_app_country] => US
[patent_app_date] => 2003-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2501
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20050106131.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504906
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504906 | Photoprotective orally administrable composition for skin | Feb 17, 2003 | Abandoned |
Array
(
[id] => 5084953
[patent_doc_number] => 20070275004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Group b streptococcus antigens'
[patent_app_type] => utility
[patent_app_number] => 10/504191
[patent_app_country] => US
[patent_app_date] => 2003-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12213
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275004.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504191 | Group b streptococcus antigens | Feb 10, 2003 | Abandoned |
Array
(
[id] => 5936017
[patent_doc_number] => 20110212120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'Ykur polynucleotides and polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/503136
[patent_app_country] => US
[patent_app_date] => 2003-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4324
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212120.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503136 | Ykur polynucleotides and polypeptides | Feb 10, 2003 | Abandoned |
Array
(
[id] => 7145256
[patent_doc_number] => 20050119172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Stabilization of protein preparations'
[patent_app_type] => utility
[patent_app_number] => 10/503520
[patent_app_country] => US
[patent_app_date] => 2003-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9101
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119172.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503520
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503520 | Stabilization of protein preparations | Feb 4, 2003 | Abandoned |
Array
(
[id] => 6925402
[patent_doc_number] => 20050238657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'Defective entities and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 10/500250
[patent_app_country] => US
[patent_app_date] => 2002-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26671
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20050238657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500250
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500250 | Defective entities and uses therefor | Dec 29, 2002 | Abandoned |
Array
(
[id] => 6966511
[patent_doc_number] => 20050233408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Modified bacterial surface layer proteins'
[patent_app_type] => utility
[patent_app_number] => 10/500307
[patent_app_country] => US
[patent_app_date] => 2002-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22516
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500307
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500307 | Modified bacterial surface layer proteins | Dec 22, 2002 | Abandoned |
Array
(
[id] => 322288
[patent_doc_number] => 07517518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-14
[patent_title] => 'Method for diagnosis of sepsis with determination of ca 125'
[patent_app_type] => utility
[patent_app_number] => 10/496173
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2962
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/517/07517518.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496173
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496173 | Method for diagnosis of sepsis with determination of ca 125 | Nov 26, 2002 | Issued |
Array
(
[id] => 4564797
[patent_doc_number] => 07858103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Method for defining, identifying and isolating fatty acid and retinal binding protein complexes having immuno-suppressive activity'
[patent_app_type] => utility
[patent_app_number] => 10/292931
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6036
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858103.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292931 | Method for defining, identifying and isolating fatty acid and retinal binding protein complexes having immuno-suppressive activity | Nov 12, 2002 | Issued |
Array
(
[id] => 7142765
[patent_doc_number] => 20050118162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Treatment of micro-organism infection'
[patent_app_type] => utility
[patent_app_number] => 10/496507
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9853
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118162.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496507 | Treatment of micro-organism infection | Nov 12, 2002 | Abandoned |
Array
(
[id] => 7010268
[patent_doc_number] => 20050063984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-24
[patent_title] => 'Antigenic peptide fragments of vapa protein, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/491300
[patent_app_country] => US
[patent_app_date] => 2002-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14924
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20050063984.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491300 | Antigenic peptide fragments of vapa protein, and uses thereof | Oct 24, 2002 | Abandoned |
Array
(
[id] => 7060609
[patent_doc_number] => 20050002969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Binary composition for prime-boost release of active ingredients like vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/492055
[patent_app_country] => US
[patent_app_date] => 2002-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2277
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20050002969.pdf
[firstpage_image] =>[orig_patent_app_number] => 10492055
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/492055 | Binary composition for prime-boost release of active ingredients like vaccines | Oct 14, 2002 | Abandoned |
Array
(
[id] => 7025433
[patent_doc_number] => 20050019827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Method for unspecific enrichment of bacterial cells'
[patent_app_type] => utility
[patent_app_number] => 10/492230
[patent_app_country] => US
[patent_app_date] => 2002-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5950
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019827.pdf
[firstpage_image] =>[orig_patent_app_number] => 10492230
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/492230 | Method for unspecific enrichment of bacterial cells | Oct 7, 2002 | Issued |